How Should We Assess Quality of Health Care Services in Organizations Owned by Private Equity Firms?

This article assesses research on private equity ownership's influence on health care quality. A review of several prominent studies supports the conclusion that private equity ownership does not have a universally positive or negative effect. Past research has found that providers backed by private equity generally have mixed quality outcomes post acquisition, depending on the sector and measures evaluated. This article outlines ways in which research findings are misconstrued and cautions against drawing conclusions from a narrow sample of literature about private equity based on studies in one sector.

Authors

Institutions

Publication Details

Journal
The AMA Journal of Ethic
Published
2025-05-01
DOI
https://doi.org/10.1001/amajethics.2025.385
Primary Topic
Pharmaceutical Economics and Policy
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

How Should We Assess Quality of Health Care Services in Organizations Owned by Private Equity Firms?

Ambar La Forgia, Ryan C. McDevitt
The AMA Journal of Ethic
Pharmaceutical Economics and Policy
article

How Should We Assess Quality of Health Care Services in Organizations Owned by Private Equity Firms?

Ambar La Forgia, Ryan C. McDevitt
article en

Abstract

This article assesses research on private equity ownership's influence on health care quality. A review of several prominent studies supports the conclusion that private equity ownership does not have a universally positive or negative effect. Past research has found that providers backed by private equity generally have mixed quality outcomes post acquisition, depending on the sector and measures evaluated. This article outlines ways in which research findings are misconstrued and cautions against drawing conclusions from a narrow sample of literature about private equity based on studies in one sector.

The AMA Journal of EthicVol. 27(5)
National Bureau of Economic Research (US), University of California, Berkeley (US)
Partnerships for the goals
Openalex Percentile: Top 87%
Pharmaceutical Economics and Policy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.